April 2016
Welcome to the April issue. Our upfront topics range from a bio-responsive insulin, to the effect of functionalized glass on the crystallization process; and Ann Hayes discusses the Drug Discovery of the Year award in In My Views. We feature the 2016 Medicine Maker Power List, celebrating brilliance and diversity found within our field. In best practice, Charlotte Miller discusses the benefits of coated tablets. In Business, we speak with Bruno Speder about how regulatory strategy can set small firms apart; and we Sit Down With Keith Thompson, Christian Schneider, Director of the National Institute for Biological Standards and Control (NIBSC), UK.
Around the World in 80 Microbes
April 26, 2016
Drug discovery doesn’t always begin in the lab…
1 min read
Controlling Crystallization
April 26, 2016
Researchers working to gain greater knowledge into crystallization believe that functionalized glass can trigger nucleation of specific crystals.
1 min read
Beyond Keeping Up Appearances
April 26, 2016
You have the perfect drug and the right packaging to protect it. All is well until the medication reaches the patient, who habitually pops the tablets into another container for easy storage or leaves them exposed to the atmosphere. Film coatings are more than just a pretty face.
1 min read
Making Small Biotech Work
April 26, 2016
Innovation is increasingly coming from small biotechs, but such companies rely on external funding to develop the compounds. A solid regulatory strategy is essential to convince investors to fund the further development.
1 min read
More Trial, Less Error
April 25, 2016
The pressure for increased efficiency pervades the pharma industry, including the clinical trials sector, where traditional supply models can lead to overstocking, waste and higher costs. Is there a more effective supply strategy?
1 min read
Back to Biologics
April 25, 2016
Sitting Down With... Christian Schneider, Director of the National Institute for Biological Standards and Control (NIBSC), UK.
1 min read
The Search for the Ideal Detector
April 25, 2016
Will aerosol-based detectors ever meet all the needs of the pharmaceutical industry?
1 min read
Time to Limit Antibiotic Pollution
April 25, 2016
The use and misuse of antibiotics is a major driver behind the drug-resistance problem, but large environmental discharges of antibiotics from pharma manufacturing can also contribute. It’s time for companies to live up to their ethical responsibilities.
1 min read
What Price Glory?
April 25, 2016
The pharmaceutical industry receives its fair share of both praise and scorn. Behind the politics, the hard work and impressive achievements of legions of industry researchers often go unnoticed.
1 min read
Moving from Batch to Continuous
April 25, 2016
The first switch from batch to continuous manufacturing has been made – and approved by the FDA. Will pharma’s future be continuous?
1 min read
Affliction Prediction
April 25, 2016
Could drug development be guided by a new algorithm that predicts the side effects of potential medicines?
1 min read
As Clear as Crystallization
April 25, 2016
Functionalized glass is shown to trigger nucleation of specific crystal forms
1 min read
Parting Shot
April 25, 2016
Sir Andrew Witty seeks to cement his legacy as GSK addresses patents and medicines access in the developing world
1 min read
Harnessing Adeno-Associated Viruses
April 25, 2016
AAV vectors are a promising tool for gene therapy and regenerative medicine, but only if they can be manufactured efficiently
1 min read
Bio-Responsive Insulin Delivery
April 25, 2016
A “smart” synthetic patch uses live pancreatic cells to painlessly deliver insulin through microneedles – on demand
1 min read
Mega-Merger Not To Be
April 25, 2016
A newly introduced tax law in the US puts an end to the would-be mega-merger between Pfizer and Allergan
1 min read
